70 results
424B5
8xf41l
26 Jan 24
Prospectus supplement for primary offering
4:08pm
424B5
v9uogjvtj7yyn89gpmm2
24 Jan 24
Prospectus supplement for primary offering
9:20pm
8-K
EX-99.3
qgt c0ppp
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.1
uohint7x 2j
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.1
dflqd5pwb 8w7xzd
8 Jan 24
Regulation FD Disclosure
9:19am
8-K
EX-10.7
eib1dmchdbv61j05h0f
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
cqrc8 mmzeey1syc5
17 Oct 23
Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio
6:35pm
8-K
EX-99.1
yv0l2pd7x
17 Oct 23
Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio
6:35pm
425
57tg6mp73lope3sw
26 Sep 23
Business combination disclosure
8:24am
8-K
EX-99.1
8fso3
26 Sep 23
Regulation FD Disclosure
8:21am
424B3
vll0tf 888u5afm9x
15 Sep 23
Prospectus supplement
6:31am
425
2e5q c09rbzee1dz
13 Sep 23
Business combination disclosure
9:14am